Krishna Institute of Medical Sciences Limited — PPTs, 06-02-2026: Investor Presentation

**1. Business Performance:**

KIMS Hospitals reported Q3 FY26 total revenue of 1,002.9 Cr, up 26.9% YoY. However, EBITDA dipped 0.4% YoY to 204.1 Cr, and PAT fell 43.9% YoY to 51.9 Cr. This profit decline was mainly due to higher finance costs, depreciation, and a fair value loss on a call option. Telangana and Andhra Pradesh remain strong profit drivers, while newer units in Maharashtra, Kerala, and Karnataka are in a ramp-up phase.

**2. Growth Drivers or Strategy:**

The company is focused on strategic expansion, planning to add over 2,000 beds via greenfield projects, acquisitions, and O&M opportunities. Key strategies include doctor partnerships with equity participation, establishing regional market leadership, and delivering affordable, quality care through advanced medical technology.

**3. Recent Developments:**

Significant ramp-up efforts are underway across new facilities. Kerala units (Kannur, Kollam) are becoming EBITDA positive, with clinical expansions and infrastructure upgrades. Maharashtra (Nashik, Thane), AP & Karnataka (Vizag QNRI, Bengaluru), and O&M units are boosting tertiary care, launching advanced specialties, and strengthening clinical teams. Bengaluru's Electronic City facility completed 16 transplants in Q3.

**4. Key Financial Metrics:**

For Q3 FY26, Total Revenue reached 1,002.9 Cr (+26.9% YoY). EBITDA was 204.1 Cr (-0.4% YoY), with PAT at 51.9 Cr (-43.9% YoY). Basic EPS stood at Rs 1.3 (-39.9% YoY).

**5. Management Commentary / Outlook:**

Management is committed to operational excellence and integrating new assets. The strategic focus on expanding bed capacity, leveraging doctor partnerships, and enhancing care through technology is expected to drive future growth and ensure new units achieve profitability within targeted timelines.